Pharma's Almanac | Capacity Expansion

80 Articles Available

1 4

CDMO Service and Capacity Expansion

Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing

PR-M05-23-01

New Biomanufacturing Facility

Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion

PR-M03-23-05

High Containment

Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India

PR-M09-22-06

Manufacturing Investment

MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France

PR-M09-22-02

Acquisition and Rebranding

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

PR-M09-22-01

Site Expansion

Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills

PR-M06-22-07

Capacity Expansion

Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business

PR-M06-22-02

New Facility

AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

PR-M05-22-13

Financial Results

Samsung Biologics Reports First Quarter 2022 Financial Results

PR-M04-22-14

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

PAO-04-022-CL-02

Ambient Storage

Yourway Adds Additional Capacity for Controlled Ambient Storage in Allentown, PA

PR-M04-22-07

Facility Acquisition

Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

PR-M04-22-01

Facility Expansion

Alcami Expands Biopharma Storage at Masy BioServices

PR-M03-22-15

Mergers and Acquisitions

Integrating Services Across the Full Spectrum of Cell and Gene Therapy

PAO-02-22-R250-10

Vaccines

IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities

PR-M01-22-13

Expansion

FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development

PR-M01-22-10

Biologics

An Evolving Biologics Landscape and Driving Innovation and Opportunity

PAO-11-21-CL-16

Expansion

German CDMO Richter-Helm Expands Plant to Serve Demand for Biologics Manufacturing

PAO-07-21-CL-08

Capacity Expansion

German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand

PR-M05-21-008

High Potency

Streamlining Highly Potent Drug Commercialization

PAO-04-21-CL-04

Biopharma

Assessing the Dynamic Market for Biologics

PAO-04-22-R221-23

Capacity Expansion

Arranta Bio Announces Mechanical Completion of Commercial-Ready Capacity for Advanced Biologics

PR-M09-20-30

Cell Therapy Capacity

Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs

PR-M09-20-NI-17

Expansion

MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion

PR-M09-20-NI-14

1 4

Capacity Expansion

80 Articles Available

Can't find what you're looking for? Try our advanced search.

CDMO Service and Capacity Expansion

Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing

New Biomanufacturing Facility

Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion

High Containment

Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India

Manufacturing Investment

MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France

Acquisition and Rebranding

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

Site Expansion

Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills

Capacity Expansion

Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business

New Facility

AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

Financial Results

Samsung Biologics Reports First Quarter 2022 Financial Results

Vaccine and Cell & Gene Therapies

Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics

Ambient Storage

Yourway Adds Additional Capacity for Controlled Ambient Storage in Allentown, PA

Facility Acquisition

Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

Facility Expansion

Alcami Expands Biopharma Storage at Masy BioServices

Mergers and Acquisitions

Integrating Services Across the Full Spectrum of Cell and Gene Therapy

Vaccines

IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities

Expansion

FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development

Biologics

An Evolving Biologics Landscape and Driving Innovation and Opportunity

Expansion

German CDMO Richter-Helm Expands Plant to Serve Demand for Biologics Manufacturing

Capacity Expansion

German CDMO Richter-Helm Triples cGMP Production Capacity to Accommodate Global Market Demand

High Potency

Streamlining Highly Potent Drug Commercialization

Biopharma

Assessing the Dynamic Market for Biologics

Capacity Expansion

Arranta Bio Announces Mechanical Completion of Commercial-Ready Capacity for Advanced Biologics

Cell Therapy Capacity

Takeda Opens New R&D Cell Therapy Manufacturing Facility to Support Expansion of Next-Generation Clinical Programs

Expansion

MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion